Related Experiment Video
Updated: May 21, 2025

A Personalized 3D-Printed Model for Preoperative Evaluation in Thyroid Surgery
Published on: February 17, 2023
Development and validation of risk prediction models for permanent hypocalcemia after total thyroidectomy in patients
BoHan Cao1, CanGang Zhang1, MingMing Jiang1
1Department of General Surgery, Benxi Central Hospital of China Medical University, No. 29 Shengli Street, Mingshan District, Benxi, 117000, Liaoning Province, China.
Abstract:
Hypocalcemia is a common complication and can be permanent in patients following total thyroidectomy (TT). The aim of this study was to identify factors associated with permanent hypocalcemia and to develop a validated risk prediction model for permanent hypocalcemia to assist surgeons in the appropriate follow-up of high-risk patients regarding supplemental therapy. We included data of 92 patients with papillary thyroid carcinoma (PTC) undergoing TT who were randomly allocated in a 7:3 ratio to a training set (n = 65) and validation set (n = 27). Univariate and multivariate logistic regression analyses revealed significant correlations of permanent hypocalcemia with parathyroid hormone (PTH) at postoperative month 1 (IM PTH), IM calcium (Ca), and IM phosphorus (P). These variables were constructed two models. Model 1 used the three indicators listed above; model 2 also included tumor, node, metastasis staging. The receiver operating characteristic (ROC) curve analysis showed that the areas under the curve (AUC) for models 1 and 2 were high for both the training set (0.905/0.913) and the validation set (0.894/0.800). Calibration curves showed good agreement between the incidence of permanent hypocalcemia estimated using the predictive models and the actual incidence. Model 1 may be more concise and convenient for clinical use.
More Related Videos
03:55Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer
Published on: June 9, 2023
06:08Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma
Published on: June 2, 2023